Research on whole genome and transcriptome integrated analyses is being explored for its potential to guide clinical care, particularly for pediatric cancers with poor prognoses. Studies are investigating the feasibility and utility of such analyses in various cancer types, including solid cancers and breast cancer. The integration of genomic tests into clinical cancer care is also being examined, with a focus on interpreting and applying the results to improve diagnosis, prognosis, and therapy.